The Belt and Road: Cooperation, Harmony and Win-Win
products

Nutraceutical

  • Asparagine Mono  CAS:5794-13-8 Manufacturer Supplier

    Asparagine Mono CAS:5794-13-8 Manufacturer Supplier

    Asparagine Mono is catalyzed by glutamine-dependent asparagine synthetase in mammalian tissues. Asparagine has high nitrogen to carbon ratio and is a key regulator for nitrogen storage and transport. Its thermal degradation in the presence of sugars leads to the acrylamide formation in foods. Asparagine Mono serves as an amino acid exchange factor and is essential for amino acid homeostasis. It favors cancer cell proliferation.

  • L-Carnitine Hydrochloride  CAS:10017-44-4 Manufacturer Supplier

    L-Carnitine Hydrochloride CAS:10017-44-4 Manufacturer Supplier

    L-Carnitine hydrochloride ((R)-Carnitine hydrochloride), a highly polar, small zwitterion, is an essential co-factor for the mitochondrial β-oxidation pathway. L-Carnitine hydrochloride functions to transport long chain fatty acyl-CoAs into the mitochondria for degradation by β-oxidation.

  • Diosmin  CAS:520-27-4  Manufacturer Supplier

    Diosmin CAS:520-27-4 Manufacturer Supplier

    Diosmin is a disaccharide derivative that consists of diosmetin substituted by a 6-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranosyl moiety at position 7 via a glycosidic linkage. It has a role as an antioxidant and an anti-inflammatory agent. It is a glycosyloxyflavone, a rutinoside, a disaccharide derivative, a monomethoxyflavone and a dihydroxyflavanone. It derives from a diosmetin.

  • Liraglutide  CAS:204656-20-2 Manufacturer Supplier

    Liraglutide CAS:204656-20-2 Manufacturer Supplier

    Liraglutide, a lipopeptide and polypeptide, is an analogue of human GLP-1 in which the lysine residue at position 27 is replaced by arginine and a hexadecanoyl group attached to the remaining lysine via a glutamic acid spacer. It is used alongside diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Liraglutide functions as a glucagon-like peptide-1 receptor agonist and serves as a neuroprotective agent.

  • TUDCA  CAS:14605-22-2 Manufacturer Supplier

    TUDCA CAS:14605-22-2 Manufacturer Supplier

    Tauroursodeoxycholic acid (TUDCA) is a hydrophilic bile acid synthesized in hepatocytes by the conjugation of ursodeoxycholic acid (UDCA) with the amino acid taurine. UDCA, which is made by gut bacteria, is FDAapproved in the United States for the treatment of certain cholestatic liver diseases. Humans make TUDCA to some extent, but it is found in copious amounts in the bile of bears. TUDCA is a classic inhibitor of endoplasmic reticulum (ER) stress.

  • Carnitine HCL  CAS:6645-46-1 Manufacturer Supplier

    Carnitine HCL CAS:6645-46-1 Manufacturer Supplier

    Carnitine HCL is an amino acid which has a role to play in the body’s fat metabolism process. L-Carnitine transports fatty acids to the mitochondria, which is where they are essentially burned as fuel. This amino acid naturally occurs, although it can also be biosynthesized from two other ones. In addition to being found in a wide range of foods, it is also commonly available as a dietary supplement.

  • DL-Alpha-Ketoisoleucine Calcium  CAS:66872-75-1

    DL-Alpha-Ketoisoleucine Calcium CAS:66872-75-1

    DL-Alpha-Ketoisoleucine Calcium is mainly used to Prevent and treat the protein metabolism disorders caused by chronic renal insufficiency.These products can be widely applied in medicine, reagent, fine chemical industry, and additive of food fields etc.

  • Pioglitazone HCL  CAS:112529-15-4 Manufacturer Supplier

    Pioglitazone HCL CAS:112529-15-4 Manufacturer Supplier

    Pioglitazone hydrochloride is an oral antidiabetic agent used in the treatment of type 2 diabetes mellitus (also known as non-insulin-dependent diabetes mellitus (NIDDM) or adult-onset diabetes.Pioglitazone is reported to be safe and well tolerated and is said to have a lower occurrence of hepatic toxicity as well as a low probability for drug interaction.

  • Solifenacin Succinate  CAS:242478-38-2 Manufacturer Supplier

    Solifenacin Succinate CAS:242478-38-2 Manufacturer Supplier

    Solifenacin succinate is an antimuscarinic medication that is used to treat an overactive bladder causing symptoms of frequency, urgency, or incontinence.Solifenacin is an M3 muscarinic receptor antagonist that was developed and launched for the treatment of overactive bladder (pollakiuria) in Europe. M3 receptors have been implicated in neurally evoked smooth muscle contractions of the bladder, and M2 receptors have also been suspected of playing a role because of their dominance in the detrusor muscle.

  • N-Acetyl-L-Alanine  CAS:97-69-8 Manufacturer Supplier

    N-Acetyl-L-Alanine CAS:97-69-8 Manufacturer Supplier

    N-acetyl-L-amino acid that is L-alanine in which one of the hydrogens attached to the nitrogen is replaced by an acetyl group.N-Acetyl-L-alanine/ 2-Acetylaminopropionic acid is crystalline solid which is used in the immunodominant determinant of acidic surface antigen from culture filtrate of human strain of Staph aureus.

  • Flutamide  CAS:13311-84-7  Manufacturer Supplier

    Flutamide CAS:13311-84-7 Manufacturer Supplier

    Flutamide is a monocarboxylic acid amide and a member of (trifluoromethyl)benzenes. It has a role as an androgen antagonist and an antineoplastic agent.Flutamide is a kind of synthetic, non-steroidal antiandrogen which is mainly used for the treatment of prostate cancer. It is a kind of toluidine derivative and a nonsteroidal antiandrogen with a similar structure of bicalutamide and nilutamide.

  • Setmelanotide  CAS:920014-72-8 Manufacturer Supplier

    Setmelanotide CAS:920014-72-8 Manufacturer Supplier

    Setmelanotide is a melanocortin 4 receptor (MC4R) agonist, which acts on human and rat MC4R; The mechanism of MC4R activation by setmelanotide may be different from that of natural ligands and the first generation synthetic agonists; Set melanotide may play a role by antagonizing the neurotransmitters that naturally exist and inhibit the activation of MC4R; It has been confirmed that Setmelanotide has a positive effect in the treatment of obesity and has reached the clinical end point of phase 3.